News
>> Leadership >> Partnerships >> News

Ativa Medical is ahead of the industry and in the news -- visit this page to stay on top of our latest product developments, events, and partnerships.

 



August 23, 2016: Ativa Invited speaker at Nex Gen Dx Summit in Washington DC

Micro Flow Cytometry: Automated Sample Prep Enabling A Broad POC Menus 

Dan McPeak, Ph.D., Director, Microfluidics, Ativa Medical

The clinical value of high-volume tests, such as CBC, is enhanced when coupled with commonly co-ordered, lower-volume assays. With a broad menu of tests available, POC practitioners would be better equipped to complete a diagnosis within the span of patient contact. This presentation discusses how Ativa Medicalís CBC technology creates opportunities for lower-volume, high-value cytometry assays at the point-of-care.

http://www.nextgenerationdx.com/point-of-care-diagnostics/




Analyzer and Test Cards
How it works
Features/Benefits
Ativa Leadership
Ativa Partnerships
Ativa News
Terms and Conditions
Privacy
Ativa Medical Corporation
1000 Westgate Drive, Suite 100
St. Paul, Minnesota 55114 612.293.3993 Direct
© Ativa Medical Corporation 2017 All rights Reserved
 
This device has not been evaluated, cleared or approved for use by the FDA, and is not for sale in the US. Safety and effectiveness have not been established.


All statements that address expectations or projections about the future, including statements about product development, market position, and financial results, are forward-looking statements. Forward-looking statements can be identified by words like "expect," "may," "could," "believe," "would," "might," "anticipates," and similar expressions. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. We undertake no obligation to update any forward-looking statements.